Skip to main content
. 2026 Jan 13;313(1):36. doi: 10.1007/s00404-025-08253-7

Table 2.

Overview of the reimbursement of fertility-preserving measures for men in Germany, Austria, and Switzerland

Criteria Germany Austria Switzerland
Reimbursement of fertility preservation before cancer therapy Yes No Yes
Lower age limit From puberty IVF Fund: from 18 years Post-pubertal
Upper age limit Up to 50 years IVF Fund: up to 50 years Up to 40 years
Criteria Benign and malignant diseases that may lead to fertility impairment Partnership, indication, health insurance, main residence of one partner, age limits, citizenship (or residence permit) Malignant and benign diseases requiring chemo- or radiotherapy, with a risk of azoospermia > 20%
Techniques

Cryopreservation of sperm

Biopsies and cryopreservation of testicular tissue

Storage up to the 50th year of age

Cryopreservation of sperm

Removal and cryopreservation of testicular tissue

Storage up to 10 years

Reimbursement of GnRH analogues No No
Sufficient cost coverage of measures No No Yes
Reimbursement of fertility preservation after cancer therapy No (possibly case-by-case decision) No No